# Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy

> **NCT00242606** · PHASE3 · COMPLETED · sponsor: **Philipps University Marburg** · enrollment: 409 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00242606
- **Lead sponsor:** Philipps University Marburg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2008-06
- **Final completion:** 2009-01
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2012-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242606, "Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00242606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*